<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ891020-0033 </DOCNO><DD> = 891020 </DD><AN> 891020-0033. </AN><HL> Business Brief -- Bristol-Myers Squibb Co.:@  Third-Quarter Profit Rose@  For Both Firms in Merger </HL><DD> 10/20/89 </DD><SO> WALL STREET JOURNAL (J) </SO><CO> BMY SQB </CO><IN> EARNINGS (ERN)DRUG MANUFACTURERS (DRG) </IN><TEXT>   Bristol-Myers Squibb Co., New York, the newly merged drug and health-care-product company, reported record third-quarter earnings for both companies in the merger.    Bristol-Myers Co. and Squibb Corp., Princeton, N.J., merged Oct. 4, but the new company reported third-period earnings for both companies. For the fourth quarter, Bristol-Myers Squibb will report one set of earnings.    Bristol-Myers said net income rose 15% to $266.2 million, or 93 cents a share, from $232.3 million, or 81 cents a share, a year earlier. Sales gained 5% to $1.59 billion from $1.52 billion.    Squibb Corp. said net rose 17% to $144.5 million, or $1.47 a share, from $123 million, or $1.25 a share. Sales were $730.1 million, up 7% from $679.5 million.    In New York Stock Exchange composite trading, Bristol-Myers Squibb rose $1.75 to $52.75. </TEXT></DOC>